These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

604 related articles for article (PubMed ID: 27475895)

  • 1. Structural Basis of Zika Virus-Specific Antibody Protection.
    Zhao H; Fernandez E; Dowd KA; Speer SD; Platt DJ; Gorman MJ; Govero J; Nelson CA; Pierson TC; Diamond MS; Fremont DH
    Cell; 2016 Aug; 166(4):1016-1027. PubMed ID: 27475895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of differential Zika and dengue virus neutralization by a public antibody lineage targeting the DIII lateral ridge.
    Zhao H; Xu L; Bombardi R; Nargi R; Deng Z; Errico JM; Nelson CA; Dowd KA; Pierson TC; Crowe JE; Diamond MS; Fremont DH
    J Exp Med; 2020 Feb; 217(2):. PubMed ID: 31757867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice.
    Sapparapu G; Fernandez E; Kose N; Bin Cao ; Fox JM; Bombardi RG; Zhao H; Nelson CA; Bryan AL; Barnes T; Davidson E; Mysorekar IU; Fremont DH; Doranz BJ; Diamond MS; Crowe JE
    Nature; 2016 Dec; 540(7633):443-447. PubMed ID: 27819683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal Antibodies against Zika Virus NS1 Protein Confer Protection via Fc
    Yu L; Liu X; Ye X; Su W; Zhang X; Deng W; Luo J; Xiang M; Guo W; Zhang S; Xu W; Yan Q; Wang Q; Cui Y; Wu C; Guo W; Niu X; Zhang F; Lei C; Qu L; Chen L; Feng L
    mBio; 2021 Feb; 12(1):. PubMed ID: 33563822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralization of Zika virus by germline-like human monoclonal antibodies targeting cryptic epitopes on envelope domain III.
    Wu Y; Li S; Du L; Wang C; Zou P; Hong B; Yuan M; Ren X; Tai W; Kong Y; Zhou C; Lu L; Zhou X; Jiang S; Ying T
    Emerg Microbes Infect; 2017 Oct; 6(10):e89. PubMed ID: 29018252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zika Virus Envelope Protein and Antibody Complexes.
    Dai L; Wang Q; Song H; Gao GF
    Subcell Biochem; 2018; 88():147-168. PubMed ID: 29900496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dengue and Zika Virus Domain III-Flagellin Fusion and Glycan-Masking E Antigen for Prime-Boost Immunization.
    Lin HH; Yang SP; Tsai MJ; Lin GC; Wu HC; Wu SC
    Theranostics; 2019; 9(16):4811-4826. PubMed ID: 31367259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Human Bi-specific Antibody against Zika Virus with High Therapeutic Potential.
    Wang J; Bardelli M; Espinosa DA; Pedotti M; Ng TS; Bianchi S; Simonelli L; Lim EXY; Foglierini M; Zatta F; Jaconi S; Beltramello M; Cameroni E; Fibriansah G; Shi J; Barca T; Pagani I; Rubio A; Broccoli V; Vicenzi E; Graham V; Pullan S; Dowall S; Hewson R; Jurt S; Zerbe O; Stettler K; Lanzavecchia A; Sallusto F; Cavalli A; Harris E; Lok SM; Varani L; Corti D
    Cell; 2017 Sep; 171(1):229-241.e15. PubMed ID: 28938115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational Engineering and Characterization of an mAb that Neutralizes Zika Virus by Targeting a Mutationally Constrained Quaternary Epitope.
    Tharakaraman K; Watanabe S; Chan KR; Huan J; Subramanian V; Chionh YH; Raguram A; Quinlan D; McBee M; Ong EZ; Gan ES; Tan HC; Tyagi A; Bhushan S; Lescar J; Vasudevan SG; Ooi EE; Sasisekharan R
    Cell Host Microbe; 2018 May; 23(5):618-627.e6. PubMed ID: 29746833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Convalescent patient-derived monoclonal antibodies targeting different epitopes of E protein confer protection against Zika virus in a neonatal mouse model.
    Niu X; Zhao L; Qu L; Yao Z; Zhang F; Yan Q; Zhang S; Liang R; Chen P; Luo J; Xu W; Lv H; Liu X; Lei H; Yi C; Li P; Wang Q; Wang Y; Yu L; Zhang X; Bryan LA; Davidson E; Doranz JB; Feng L; Pan W; Zhang F; Chen L
    Emerg Microbes Infect; 2019; 8(1):749-759. PubMed ID: 31130109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational Design of Zika Virus Subunit Vaccine with Enhanced Efficacy.
    Tai W; Chen J; Zhao G; Geng Q; He L; Chen Y; Zhou Y; Li F; Du L
    J Virol; 2019 Sep; 93(17):. PubMed ID: 31189716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural Basis for Neutralization and Protection by a Zika Virus-Specific Human Antibody.
    Wang L; Wang R; Wang L; Ben H; Yu L; Gao F; Shi X; Yin C; Zhang F; Xiang Y; Zhang L
    Cell Rep; 2019 Mar; 26(12):3360-3368.e5. PubMed ID: 30893607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant lipidated Zika virus envelope protein domain III elicits durable neutralizing antibody responses against Zika virus in mice.
    Chen MY; Chai KM; Chiang CY; Wu CC; Yu GY; Liu SJ; Chen HW
    J Biomed Sci; 2020 Apr; 27(1):51. PubMed ID: 32290844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human antibody response to Zika targets type-specific quaternary structure epitopes.
    Collins MH; Tu HA; Gimblet-Ochieng C; Liou GA; Jadi RS; Metz SW; Thomas A; McElvany BD; Davidson E; Doranz BJ; Reyes Y; Bowman NM; Becker-Dreps S; Bucardo F; Lazear HM; Diehl SA; de Silva AM
    JCI Insight; 2019 Apr; 4(8):. PubMed ID: 30996133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large-scale analysis of B-cell epitopes of envelope: Implications for Zika vaccine and immunotherapeutic development.
    Almansour I; Alfares R; Aljofi H
    F1000Res; 2018; 7():1624. PubMed ID: 31316749
    [No Abstract]   [Full Text] [Related]  

  • 16. Investigation of the immunogenicity of Zika glycan loop.
    Henderson EA; Tam CC; Cheng LW; Ngono AE; Nguyen AV; Shresta S; McGee M; Padgett H; Grill LK; Martchenko Shilman M
    Virol J; 2020 Mar; 17(1):43. PubMed ID: 32234060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis of a potent human monoclonal antibody against Zika virus targeting a quaternary epitope.
    Long F; Doyle M; Fernandez E; Miller AS; Klose T; Sevvana M; Bryan A; Davidson E; Doranz BJ; Kuhn RJ; Diamond MS; Crowe JE; Rossmann MG
    Proc Natl Acad Sci U S A; 2019 Jan; 116(5):1591-1596. PubMed ID: 30642974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Antigenic Site Spanning Domains I and III of the Zika Virus Envelope Glycoprotein Is the Target of Strongly Neutralizing Human Monoclonal Antibodies.
    Graham SD; Tu HA; McElvany BD; Graham NR; Grinyo A; Davidson E; Doranz BJ; Diehl SA; de Silva AM; Markmann AJ
    J Virol; 2021 Apr; 95(9):. PubMed ID: 33597214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zika Virus-Like Particles Bearing a Covalent Dimer of Envelope Protein Protect Mice from Lethal Challenge.
    De Lorenzo G; Tandavanitj R; Doig J; Setthapramote C; Poggianella M; Sanchez-Velazquez R; Scales HE; Edgar JM; Kohl A; Brewer J; Burrone OR; Patel AH
    J Virol; 2020 Dec; 95(1):. PubMed ID: 33028720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatic Hypermutation and Framework Mutations of Variable Region Contribute to Anti-Zika Virus-Specific Monoclonal Antibody Binding and Function.
    Tsuji I; Vang F; Dominguez D; Karwal L; Sanjali A; Livengood JA; Davidson E; Fouch ME; Doranz BJ; Das SC; Dean HJ
    J Virol; 2022 Jun; 96(11):e0007122. PubMed ID: 35575481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.